In BCC, the interaction of HH/GLI and pro-inflammatory IL6/signal transducer and activator of transcription-3 (STAT3) signaling synergistically regulates common GLI-STAT3 target genes and promotes cancer proliferation (Fig. 1) [87, 88]. This evidence concerns the gene STAT3 and skin basal cell carcinoma.